Systemic treatment of immune checkpoint inhibitor‐induced psoriasis: Inference‐based guidance
Journal of the European Academy of Dermatology and Venereology, EarlyView.When managing psoriasis, induced or exacerbated by ICI therapy for cancer, there are concerns regarding immunosuppression from systemic agents for the treatment of psoriasis and the potential impact on ICI efficacy. No direct, high‐level evidence exists to address these concerns.
Kim A. Papp +14 more
wiley +1 more source
Improvement and maintenance of clinical outcome assessments in atopic dermatitis with amlitelimab
Journal of the European Academy of Dermatology and Venereology, EarlyView.Clinical outcome assessments (COAs) were evaluated in the STREAM‐AD phase 2b trial investigating amlitelimab in patients with moderate‐to‐severe atopic dermatitis. Amlitelimab improved COAs at Week 24 versus placebo. The majority of patients achieving clinically meaningful COA improvements at Week 24 who continued/withdrew from amlitelimab maintained ...
Andrew Blauvelt +8 more
wiley +1 more source
Feasibility and usability of three consecutive nights with self‐applied, home polysomnography
Journal of Sleep Research, Volume 34, Issue 2, April 2025.Summary In‐laboratory polysomnography, the gold‐standard for diagnosing sleep disorders, is resource‐demanding and not conducive to multiple night evaluations. Ambulatory polysomnography, especially when self‐applied, could be a viable alternative. This study aimed to assess the feasibility and reliability of self‐applied polysomnography over three ...
Dimitri Ferretti +7 more
wiley +1 more source
The Dental Status of Patients Taking Common Biologic Agents: A Single‐Center Cross‐Sectional Study
Oral Diseases, EarlyView.ABSTRACT Objectives Despite expanding use and medical applications, little is known about the impact of biologic agents (BAs) on dental treatment. The aim of this study was to investigate the dental status of patients on common classes of BAs to understand treatment needs and use in this population.
Shivani Shah +4 more
wiley +1 more source
Anti- and non-tumor necrosis factor-α-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. [PDF]
World J Diabetes, 2021 Wang CR, Tsai HW.
europepmc +1 more source
Musculoskeletal Care, Volume 23, Issue 3, September 2025.ABSTRACT Introduction Inflammatory arthritis (IA) is a chronic autoimmune condition characterised by joint pain, fatigue and other symptoms. Often diagnosed during peak parenting years, IA presents unique challenges to fulfilling parenting roles. Occupational therapy researchers have emphasised the need to better understand parenting as a valued ...
Catherine White +2 more
wiley +1 more source
Correlations of fatigue in Danish patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis. [PDF]
PLoS One, 2020 Esbensen BA +4 more
europepmc +1 more source
Thriving when living with chronic pain: A qualitative evidence synthesis of individuals' experiences
British Journal of Health Psychology, Volume 30, Issue 3, September 2025.Abstract Introduction Research has begun to focus on positive adjustment to, and aspects of, living with chronic pain, which aligns with a positive psychology approach. This systematic review aimed to synthesize available qualitative data to understand the characteristics and approaches that enable people to thrive whilst living with chronic pain ...
Helena Widdrington +4 more
wiley +1 more source
Diverse Treatment Goals in Psoriatic Arthritis: Insights From Participants in the PARC Cohort
Arthritis Care &Research, Volume 77, Issue 8, Page 1007-1013, August 2025.Objective The aim of this study was to examine patient‐reported treatment goals among individuals with psoriatic arthritis. Methods Participants in the Psoriatic Arthritis Research Consortium completed standardized assessments, including patient‐reported outcome (PROs) instruments, between 2017 and 2020.
Astia Allenzara +8 more
wiley +1 more source